All In MedTech

FDA Clearance Tracker · P170002-S048

RHA® Dynamic Volume, RHA®4

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 18, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 18, 2025

Approved

Time to decision

290 days

Received Dec 2, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P170002-S048
Device name
RHA® Dynamic Volume, RHA®4
Applicant
Teoxane S.A.
Applicant location
Geneva
Received
Dec 2, 2024
Decided
Sep 18, 2025
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P170002

Device type

Device class
Class III

Every decision under product code LMH

FDA's approval statement

As written in FDA's record.

Approval for RHA®4 and RHA® Dynamic Volume for expanding the indications to include injection into the subcutaneous to supraperiosteal layers for cheek augmentation and/or correction of age-related midface contour deficiencies in patients aged 22 or older.

Source documents

Other decisions for Teoxane S.A.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.